Aug 21, 2007|
FMCG midcaps: Feel good
Earlier we had analysed the performance of the FMCG biggies for the June quarter. In this article, we have highlighted the performance of the smaller FMCG players namely Marico, Colgate, Godrej Consumers (GCPL) and GSK Consumer.
FMCG midcap companies' results for the June quarter have been stronger in comparison to the large caps for the same quarter. The consolidated topline (4 companies combined) grew by over 20% YoY, faster than the topline growth of the larger peers.
|Operating profit (EBDITA)
|EBDITA margin (%)
|Profit before tax
|Profit after tax/(loss)
|Net profit margin (%)
India has continued to reach new heights in the economic sphere. Real economy grew by 8% fuelled by strong growth in the service and manufacturing sectors. Besides more and more consumers willing to buy new products, with a strong job scenario, the disposable incomes are also on a rise. The smaller players are more focused on the urban areas as compared to biggies of the sector, which have a greater penetration even in the rural areas. FMCG markets both in the rural and urban areas witnessed strong growth with growth being seen in both food and non-food products.
Another trend, which was visible, was the "Feel Good" categories of products doing well. Hair care, skin care products witnessed higher volumes. Colgate reported a 13% YoY growth in the topline during 1QFY08. The company achieved a strong 9% YoY volume increase led by a 10% growth in its core toothpaste category. In case of Marico, the focus segment of the hair-care range (Parachute Jasmine, Shanti Amla Badam, and Hair & Care) grew by 20% in volume terms (excluding Nihar) for the June quarter, while Kaya Skin care recorded 31% YoY growth. Also, healthy foods are in demand owing to urban consumers getting more conscious about their well being and hence demanding nutritious products. Marico's strategy to promote Saffola on a health consciousness platform paid off with its franchise growing by 28% YoY in volume terms. GSK Consumer reported a topline growth of 18% YoY for the quarter, with its flagship brands growing by 18% in value terms. Further the strong growth in the topline was also witnessed due to contribution from acquisitions and international ventures.
The beauty and the wellness segment would continue to be the future driver. Increasing awareness and expectations, rising incomes, willingness to spend and a variety of new products offered by the companies would led to the strong growth in this segment. The small FMCG players are planning to launch higher end products to capture more market share.
The smaller players also witnessed a rise in operating margins as they offered high end products. For instance, Godrej Consumer Products introduced the Keyline product in India and expects to get more products in the coming quarters. Also, the ad spend in this quarter was lesser as phasing was done by the companies. Godrej Consumer Products reported the biggest reduction of 15.7% in advertising and sales promotions expenditure while Marico, reduced spends by 10%. However, going forward the ad spends are expected to rise, as new products are likely to be introduced over the coming quarters.
Higher operating income, lower depreciation charges and tax expenses led to the bottomline growth of 40% YoY in the quarter, thus outpacing the growth in net profits of their larger peers (up 23% YoY).
The personal care segment would continue its growth trend with newer, higher end products hitting the shelf in the coming quarters. Growth in the FMCG sector is expected to remain vibrant. Also, we believe that the small players would increase their penetration in the rural areas. As per industry estimates, the total size of the domestic FMCG market in volume terms is US$ 15 bn, of which US$ 7.9 bn come from rural areas, US$ 2.9 bn from the semi-urban markets, while the metros and other cities contribute US$ 4.2 bn. The FMCG market in the rural and semi-urban regions is likely to grow at a faster pace in the next three years.
More Views on News
Aug 9, 2017
While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Dec 9, 2016
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
Nov 30, 2016
Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
Nov 30, 2016
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
Nov 28, 2016
Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407